Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Metabolic Effects of Cocaine

This study has been completed.
Sponsor:
Collaborator:
National Alliance for Research on Schizophrenia and Depression
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00451230
First received: March 22, 2007
Last updated: January 17, 2017
Last verified: October 2002

March 22, 2007
January 17, 2017
June 2005
June 2005   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00451230 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Metabolic Effects of Cocaine
Elucidating the Role of the Hypothalamic-Pituitary-Adrenal (HPA) Axis in the Mechanisms Underlying Cocaine Dependence
The goal of this this study is to elucidate the role of the HPA axis in the pathophysiology of cocaine dependence
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double-Blind
Cocaine Dependence
  • Drug: cocaine
  • Drug: hydrocortisone
Not Provided
Rott D, Langleben DD, Elman I. Cocaine decreases plasma insulin concentrations in non-diabetic subjects: a randomized double-blind study. Diabet Med. 2008 Apr;25(4):510-1. doi: 10.1111/j.1464-5491.2008.02412.x. Epub 2008 Mar 13.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
15
June 2005
June 2005   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Individuals with DSM IV diagnosis of cocaine dependence, medically healthy

Exclusion Criteria:

  • Other than cocaine dependence DSM-IV axis I diagnosis
Sexes Eligible for Study: All
21 Years to 49 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00451230
2000p 000323
DA#14410
No
Not Provided
Not Provided
Not Provided
Not Provided
National Institute on Drug Abuse (NIDA)
National Alliance for Research on Schizophrenia and Depression
Principal Investigator: Igor Elman MGH
National Institute on Drug Abuse (NIDA)
October 2002

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP